Innealta Capital’s Qiagen QGEN Stock Holding History

Innealta Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,126	Closed	-$205K	–	100
2026 Q1	$205K	Buy	+5,126	New	+$243K	0.13%	70

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Innealta Capital's QGEN Position: Q2 2026 in Review

Innealta Capital sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 5,126 shares — an estimated $205K sold.

Innealta Capital first reported a position in QGEN in Q1 2026 and held it in 1 quarter. The position peaked at $205K in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Innealta Capital reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Innealta Capital sold 5,126 Qiagen shares in Q2 2026, an estimated $205K.
Innealta Capital first reported a position in Qiagen in Q1 2026 and held it in 1 quarter.
Innealta Capital's Qiagen position peaked at $205K in Q1 2026.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Innealta Capital's 13F filing for Q2 2026, filed 4 Aug 2026.